Supplemental Figure 2 from A Phase 0/I Pharmacokinetic and Pharmacodynamics and Safety and Tolerability Study of Letrozole in Combination with Standard Therapy in Recurrent High-Grade Gliomas
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
Supplemental Figure 2: Gender-based comparison of Tumoral LTZ and E2 concentrations across the five-dose cohorts
Preguntar a la IA
Me gusta
Guardar
Compartir
Ver artículo completo
Preguntar a la IA
Me gusta
Guardar
Compartir
Ver artículo completo
Supplemental Figure 2 from A Phase 0/I Pharmacokinetic and Pharmacodynamics and Safety and Tolerability Study of Letrozole in Combination with Standard Therapy in Recurrent High-Grade Gliomas | Synapse